Cited by 7Redox biology and oxidative stressAntioxidant Activity and Oxidative StressCholesterol and Lipid Metabolism

Redox equilibrium of serum apolipoprotein E3: a buffering effect of disulfide-linked complexes against oxidative stress on apolipoprotein E3–containing lipoproteins

Open access
Yamauchi, Kazuyoshi, Iwasaki, Shio, Kawakami, Yasushi·2019·Bioscience Reports

Abstract

Reversible redox modification of cysteine thiols is crucial for protecting proteins from irreversible detrimental change. However, the physiological significance of the redox modification of apolipoprotein (apo) E is unclear. Here, we hypothesized that the disulfide-linked complexes of apoE3 corresponding to the representative reversible-modified apoE3 play a protective role against oxidative stress. The effects of disulfide bond formation on oxidative stress on apoE3 were evaluated with a band-shift assay. Maleimide-labeled apoE3 and unlabeled apoE3 were defined as the reduced (r)-apoE3 and non-reduced (nr)-apoE3 forms, respectively. Hydrogen peroxide-induced oxidation decreased for reduced-form apoE (r-apoE3) but increased for nr-apoE3. Induction of apoE3-AII complex formation with excess of apoAII markedly suppressed the oxidative stress-induced increase in nr-apoE3 (P<0.001) and enhanced homodimer formation. The apoE3-AII complex was more dominant in high-density lipoprotein (HDL) than in very low-density lipoprotein. Under oxidative stress, HDL showed a significant decrease, rather than an increase, in nr-apoE3 levels with a concomitant significant increase in apoE3-AII levels (P<0.005). This finding suggests that the majority of nr-apoE3 in HDL exists in a reversible oxidized form. The apoE3-AII complex, formed from the reversible oxidized apoE3, is beneficial for maintaining the redox equilibrium of apoE3 by preventing the modification of apoE3 to its irreversible oxidized form. The apoE3-AII complex may be possibly implicated in the pathophysiology of various apoE-related diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bsr20190184

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 22

  1. [1]Mahley R.W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622– 630 10.1126/science.3283935 3283935 · DOI · Paper page
  2. [2]Huang Y. and Mahley R.W. (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases. Neurobiol. Dis. 72, 3– 12 10.1016/j.nbd.2014.08.025 25173806 PMC4253862 · DOI · Paper page
  3. [3]Mahley R.W. (2016) Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J. Mol. Med. (Berl) 94, 739– 746 10.1007/s00109-016-1427-y 27277824 PMC4921111 · DOI · Paper page
  4. [4]Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921– 923 10.1126/science.8346443 8346443 · DOI · Paper page
  5. [5]Rebeck G.W., Reiter J.S., Strickland D.K. and Hyman B.T. (1993) Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11, 575– 580 10.1016/0896-6273(93)90070-8 8398148 · DOI · Paper page
  6. [6]Weisgraber K.H. and Shinto L.H. (1991) Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J. Biol. Chem. 266, 12029– 12034 2050696
  7. [7]Weisgraber K.H. and Mahley R.W. (1978) Apoprotein (E–A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J. Biol. Chem. 253, 6281– 6288 210174
  8. [8]Tozuka M., Hidaka H., Miyachi M., Furihata K., Katsuyama T. and Kanai M. (1992) Identification and characterization of apolipoprotein(AII-E2-AII) complex in human plasma lipoprotein. Biochim. Biophys. Acta 1165, 61– 67 10.1016/0005-2760(92)90076-8 1420349 · DOI
  9. [12]Thomas J.A., Poland B. and Honzatko R. (1995) Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch. Biochem. Biophys. 319, 1– 9 10.1006/abbi.1995.1261 7771771 · DOI
  10. [14]Zheng M., Aslund F. and Storz G. (1998) Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279, 1718– 1721 10.1126/science.279.5357.1718 9497290 · DOI
  11. [15]Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M. and Yodoi J. (2002) Redox control of cell death. Antioxid. Redox. Signal. 4, 405– 414 10.1089/15230860260196209 12215208 · DOI
  12. [16]Go Y.M. and Jones D.P. (2013) The redox proteome. J. Biol. Chem. 288, 26512– 26520 10.1074/jbc.R113.464131 23861437 PMC3772199 · DOI · Paper page
  13. [17]Yamauchi K., Ebihara Y. and Kawakami Y. (2017) Redox status of serum apolipoprotein E and its impact on HDL cholesterol levels. Clin. Biochem. 50, 777– 783 10.1016/j.clinbiochem.2017.03.021 28366823 · DOI
  14. [18]Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T. and Otagiri M. (2005) The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst. Biochem. Biophys. Res. Commun. 334, 1322– 1328 10.1016/j.bbrc.2005.07.035 16054887 · DOI
  15. [19]Kawakami A., Kubota K., Yamada N., Tagami U., Takehana K., Sonaka I. (2006) Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions. FEBS. J. 273, 3346– 3357 10.1111/j.1742-4658.2006.05341.x 16857017 · DOI
  16. [20]Anraku M., Chuang V.T., Maruyama T. and Otagiri M. (2013) Redox properties of serum albumin. Biochim. Biophys. Acta 1830, 5465– 5472 10.1016/j.bbagen.2013.04.036 23644037 · DOI
  17. [21]Havel R.J., Eder H.A. and Bragdon J.H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345– 1353 10.1172/JCI103182 13252080 PMC438705 · DOI
  18. [22]Yamauchi K., Tozuka M., Hidaka H., Hidaka E., Kondo Y. and Katsuyama T. (1999) Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E. Clin. Chem. 45, 1431– 1438 10471645
  19. [23]Stoffel W. (1984) Synthesis, transport, and processing of apolipoproteins of high density lipoproteins. J. Lipid. Res. 25, 1586– 1592 6442339
  20. [24]Kadota K., Yui Y., Hattori R., Murohara Y. and Kawai C. (1991) Decreased sulfhydryl groups of serum albumin in coronary artery disease. Jpn. Circ. J. 55, 937– 941 10.1253/jcj.55.937 1744980 · DOI
  21. [25]Oettl K., Birner-Gruenberger R., Spindelboeck W., Stueger H.P., Dorn L., Stadlbauer V. (2013) Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J. Hepatol. 59, 978– 983 10.1016/j.jhep.2013.06.013 23811308 · DOI
  22. [27]Liu C.C., Liu C.C., Kanekiyo T., Xu H. and Bu G. (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106– 118 10.1038/nrneurol.2012.263 23296339 PMC3726719 · DOI · Paper page

Cited by

Sorted by citations

Authors
Yamauchi, K., Iwasaki, S., & Kawakami, Y.
Affiliations
University of Tsukuba (JP)
Corresponding author
Yamauchi, Kazuyoshi
Venue
Bioscience Reports
Published
2019-04
Volume
39
Issue
4
Pages
BSR20190184
ISSN
  • 0144-8463 (ISSN-L)
  • 1573-4935
OpenAlex
W2931017505
Cited by
7
References
5
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 1
FWCI
0.17
Type
journal article
Language
en
Open access
Locations
  • Bioscience Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (acceptedVersion, cc-by)
  • Terrestrial Environment Research Center (University of Tsukuba) (submittedVersion, cc-by)
Funders
Japan Society for the Promotion of Science (18K07461)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
apolipoprotein E3, apolipoprotein A-II, redox equilibria, oxidative stress, hydrogen peroxide, high-density lipoprotein, VLDL, protein homodimerization
MeSH terms
Apolipoproteins E, Disulfides, Humans, Hydrogen Peroxide, Lipoproteins, HDL, Lipoproteins, VLDL, Maleimides, Oxidation-Reduction, Oxidative Stress, Protein Isoforms, Apoprotein(a), Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review